Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix Products
PremiumPress ReleasesAziyo Biologics Announces Voluntary Recall of Viable Bone Matrix Products
1y ago
Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope
PremiumPress Releases
Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope
1y ago
Aziyo Biologics Reports Highest Sales and Gross Profit in Company History
PremiumPress Releases
Aziyo Biologics Reports Highest Sales and Gross Profit in Company History
1y ago
Aziyo Biologics Reports Record Full Year 2022 Revenues
PremiumPress ReleasesAziyo Biologics Reports Record Full Year 2022 Revenues
1y ago
Aziyo Biologics, Sientra team on SimpliDerm for soft tissue reconstruction
PremiumThe Fly
Aziyo Biologics, Sientra team on SimpliDerm for soft tissue reconstruction
1y ago
Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women’s Access to Biologics for Soft Tissue Reconstruction
PremiumPress Releases
Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women’s Access to Biologics for Soft Tissue Reconstruction
1y ago
Aziyo Biologics announces funding of additional $4M term loan
PremiumThe FlyAziyo Biologics announces funding of additional $4M term loan
2y ago
Aziyo Biologics Announces Funding of Additional $4 Million Term Loan with SWK Holdings Corporation
PremiumPress Releases
Aziyo Biologics Announces Funding of Additional $4 Million Term Loan with SWK Holdings Corporation
2y ago
Aziyo Biologics 2.35M share Spot Secondary priced at $4.75
PremiumThe Fly
Aziyo Biologics 2.35M share Spot Secondary priced at $4.75
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100